Concepedia

Stellan Båtsman

SB

4

Publications

1.3K

Citations

4

H-Index

2000

Active since

Affiliations

Sahlgrenska University Hospital(Current)

Umeå University

Karolinska University Hospital

Malmö University

Linköping University Hospital

Stellan Båtsman is an author at Sahlgrenska University Hospital specializing in neurology, neurodegenerative diseases, and alzheimer's disease.

Top concepts

Publications per year

2000–2008

4

Publications

4

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lars Lannfelt, Kaj Blennow, Henrik Zetterberg et al. · The Lancet Neurology · 2008 · 697 citations

, , +10

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

Bengt Winblad, Lena Kilander, Sture Eriksson et al. · The Lancet · 2006 · 384 citations

, , +10

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

Kaj Blennow, Anne Ricksten, Jonathan A. Prince et al. · Journal of Neural Transmission · 2000 · 105 citations

, , +12

Donepezil in Alzheimer’s Disease: What to Expect after 3 Years of Treatment in a Routine Clinical Setting

Åsa K. Wallin, Niels Andreasen, Sture Eriksson et al. · Dementia and Geriatric Cognitive Disorders · 2006 · 83 citations

Rows per page

1–4 of 4